Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26169758 | 1.00 | TSHR (0.53) | TSHRHSD17B10L3MBTL1TDP1CYP19A1 | |
| SCHEMBL7220029 | 0.93 | TSHR (0.44) | TSHRHSD17B10L3MBTL1TDP1ALDH1A1 | |
| SCHEMBL7219748 | 0.86 | PDCD1 (0.38) | TSHRHSD17B10CYP19A1 | |
| SCHEMBL27563659 | 0.82 | TDP1 (0.57) | HSD17B10L3MBTL1TDP1PTGS2CYP3A4 | |
| SCHEMBL27733869 | 0.80 | TDP1 (0.59) | HSD17B10L3MBTL1TDP1PTGS2CYP3A4 | |
| Hydrochloric Acid SCHEMBL28015977 | 0.78 | TDP1 (0.57) | HSD17B10L3MBTL1TDP1PTGS2CYP3A4 | |
| SCHEMBL23026423 | 0.77 | PDCD1 (0.35) | TSHRHSD17B10L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL197194 | 0.77 | TDP1 (0.52) | HSD17B10L3MBTL1TDP1PTGS2CYP3A4 | |
| SCHEMBL18728443 | 0.75 | CYP11B1 (0.36) | HSD17B10ALDH1A1HPGD | |
| SCHEMBL19909258 | 0.75 | TDP1 (0.50) | HSD17B10L3MBTL1TDP1PTGS2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10807968-B2 | Substituted 2-(het)arylimidazolylcarboxyamides as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-10-20 | — | — | US | disclosed |
| US-20200048221-A1 | SUBSTITUTED 2-(HET)ARYLIMIDAZOLYLCARBOXYAMIDES AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048221-A1 | SUBSTITUTED 2-(HET)ARYLIMIDAZOLYLCARBOXYAMIDES AS PESTICIDES | DDT, CYP4X1, CYP4Z1 | TSHR 1122/4885HSD17B10 1818/4885L3MBTL1 1319/4885 |
| US-10807968-B2 | Substituted 2-(het)arylimidazolylcarboxyamides as pesticides | DDT, CYP4X1, CYP4Z1 | TSHR 1122/4885HSD17B10 1818/4885L3MBTL1 1319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.